Inclusion and exclusion criteria of literature Inclusion criteria: 1) Study type: randomized controlled trial (RCTs) or quasi-randomized controlled trial
Until these trials are complete and regulatory submissions are made, the full picture of retatrutide's side effect profile including the true burden of nausea in real-world use remains to be established
Ozempic and Mounjaro are licensed for type 2 diabetes
The amylin pathway adds a layer of appetite regulation that GLP-1 agonists simply cannot reach on their own
The comment was made 4 monthsHi Elise, This is not suitable for the eye area, so I recommend using a specially designed product for that Wishing you a nice day
placebo Population: T2D with established CVD or high CV risk Study Objectives: Primary Endpoint: Time to first occurrence of 3-point MACE (CV death, non-fatal MI, non-fatal stroke) Secondary Endpoints: Heart failure hospitalization, all-cause mortality, kidney outcomes Anticipated Results: Expected completion 2025
